Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by diadon1945on Feb 11, 2008 8:28pm
128 Views
Post# 14353845

RE: Bellini bought 300,000 shares at 31 cents....

RE: Bellini bought 300,000 shares at 31 cents....We are agreed that Bellini thinks this company will do well or he would not have put his money into 300,000 shares above what he already has in options. One reason may be that he and his wife are already putting more money into NRM which he is very busy reshaping with a new neutraceutical focus and a second generation Alzheimers drug. What I can't help but wonder about is why he invests in SSS at all...it is a very small off the radar company...but also why he came onto the Board of directors! What are his intentions in the longer run? What does he see here that most investors are missing? He is not only very wealthy...he is also a brilliant scientist. I can see that if you look at all the indications that adult stem cell stimulation may treat(or even cure!)...they add up to a market potential of in excess of $70 Billion (Stroke,TBI,MS,Alzheimers,Parkinsons,Huntingtons,Schizophrenia,ALS,etc.etc.) What Bellini's presence on the board says to me is that he thinks the science is good! That being the case what might his next steps be? Chair the Board? Become the next CEO? Buy out the company? I'm waiting for Bellini to drop the next shoe! I don't think he is the kind of man to waste his time on something that does not have a very big future. Bellini has said he has the vision of developing a very big pharmaceutical company. Is that possible with NRM? Or is it even more likely with SSS? The potential of this company is huge!
Bullboard Posts